These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3374477)

  • 41. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
    Rainsford KD; Ying C; Smith FC
    J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphocytes induce resorption of cartilage by producing catabolin.
    Saklatvala J; Sarsfield SJ
    Biochem J; 1982 Jan; 202(1):275-8. PubMed ID: 7082313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
    Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
    J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones.
    Conaway HH; Grigorie D; Lerner UH
    J Endocrinol; 1997 Dec; 155(3):513-21. PubMed ID: 9487996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1beta-stimulated catabolism.
    Sztrolovics R; Recklies AD; Roughley PJ; Mort JS
    Biochem J; 2002 Mar; 362(Pt 2):473-9. PubMed ID: 11853557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
    Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
    J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Turnover of proteoglycans in cultures of bovine articular cartilage.
    Campbell MA; Handley CJ; Hascall VC; Campbell RA; Lowther DA
    Arch Biochem Biophys; 1984 Oct; 234(1):275-89. PubMed ID: 6486821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of interleukin-1-induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C.
    Arner EC; Pratta MA
    Arthritis Rheum; 1991 Aug; 34(8):1006-13. PubMed ID: 1859477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of arachidonic acid release as the mechanism by which glucocorticoids inhibit endotoxin-induced diarrhoea.
    Doherty NS
    Br J Pharmacol; 1981 Jun; 73(2):549-54. PubMed ID: 7237001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of glucocorticoids on calf cartilage sulphate metabolism in vitro.
    Ezer E; Boström H
    Acta Physiol Acad Sci Hung; 1968; 33(1):47-50. PubMed ID: 5657138
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cortisol on cell proliferation and proteoglycan synthesis and degradation in cartilage zones of the calf costochondral growth plate in vitro with and without rat plasma somatomedin activity.
    Hill DJ
    J Endocrinol; 1981 Mar; 88(3):425-35. PubMed ID: 7217829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
    Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
    Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biosynthesis of proteoglycan in vitro by cartilage from human osteochondrophytic spurs.
    Malemud CJ; Goldberg VM; Moskowitz RW; Getzy LL; Papay RS; Norby DP
    Biochem J; 1982 Aug; 206(2):329-41. PubMed ID: 6816221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation.
    Janusz MJ; Hare M
    J Immunol; 1993 Mar; 150(5):1922-31. PubMed ID: 8436825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of proteoglycan degradation by a neutral protease from human growth-plate epiphyseal cartilage.
    Ehrlich MG; Armstrong AL; Neuman RG; Davis MW; Mankin HJ
    J Bone Joint Surg Am; 1982 Dec; 64(9):1350-4. PubMed ID: 6754738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The site of cartilage matrix degradation.
    Dingle JT; Dingle TT
    Biochem J; 1980 Aug; 190(2):431-8. PubMed ID: 7470058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis.
    Kang Y; Eger W; Koepp H; Williams JM; Kuettner KE; Homandberg GA
    J Orthop Res; 1999 Nov; 17(6):858-69. PubMed ID: 10632453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation.
    Buttle DJ; Saklatvala J
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):657-61. PubMed ID: 1445226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Degradation of proteoglycan in articular cartilage.
    Sandy JD; Brown HL; Lowther DA
    Biochim Biophys Acta; 1978 Nov; 543(4):536-44. PubMed ID: 31190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.